Financial Year |
March 31 2023 |
Monetary Funds |
334,958,530.92 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
1,124,596.17 |
Accounts Receivable |
232,713,045.87 |
Advances to Suppliers |
93,787,576.90 |
Other Receivables |
12,433,643.91 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
476,212,763.87 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
4,814,451.92 |
Total Current Assets |
1,237,741,355.12 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
32,765,034.68 |
Investment Properties |
-- |
Fixed Assetes |
173,449,385.62 |
Under-construction Projects |
201,049,163.60 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
100,909,979.62 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
8,618,807.33 |
Other Non-Current Assets |
43,527,003.32 |
Sub-Total of Non-Current Assets |
569,675,003.47 |
Total Assets |
1,807,416,358.59 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
151,211,640.17 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
27,008,009.80 |
Taxes Payable |
12,897,820.21 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
2,861,330.40 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
3,439,783.14 |
Other Current Liabilities |
35,462,548.75 |
Sub-Total of Current Liabilities |
541,658,337.02 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
816,607.14 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
21,578,719.29 |
Total Liabilities |
563,237,056.31 |
Paid-In Capital(Or Share Stock) |
189,263,526.00 |
Capital Surplus |
540,030,475.71 |
Surplus Reserve |
46,359,104.60 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
448,571,262.71 |
Minority Stockholder's Interest |
4,458,534.94 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,239,720,767.34 |
Owner's Equity(Stockholder's Equity) |
1,244,179,302.28 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,807,416,358.59 |